Pancreatic Cancer Research

ResearcherOsaka International Cancer InstituteActive in the last 2 years

Masato Sakon

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2703-3385; OpenAlex author ID A5059872605. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
22
Papers, trials and grants by year

2015: 2 papers · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 2 papers · 2024: 1 paper

Papers 11

  1. The preliminary analysis of lymphatic flow around the connective tissues surrounding SMA and SpA elucidates patients' oncological condition in borderline-resec… Co-author DOI 10.1186/s12893-024-02398-z↗
  2. Pathological Nodal and Vascular Involvement Significantly Impacts the Recurrence Risk in Different Time Frames in Patients With Resectable and Borderline Resec… Co-author DOI 10.1097/sla.0000000000005879↗
  3. DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancer. Last author DOI 10.1186/s12885-023-10512-2↗
  4. Difference between carbohydrate antigen 19-9 and fluorine-18 fluorodeoxyglucose positron emission tomography in evaluating the treatment efficacy of neoadjuvan… Last author DOI 10.1002/ags3.12418↗
  5. Clinical implications of the serum CA19-9 level in "biological borderline resectability" and "biological downstaging" in the setting of preoperative chemoradia… Co-author DOI 10.1016/j.pan.2020.05.020↗
  6. The utility of nutritional supportive care with an eicosapentaenoic acid (EPA)-enriched nutrition agent during pre-operative chemoradiotherapy for pancreatic c… Last author DOI 10.1016/j.clnesp.2019.06.003↗
  7. Subclinical cancer cell dissemination in peritoneal lavage fluid detected by reverse-transcription polymerase chain reaction identifies patients at high risk f… Co-author DOI 10.1016/j.surg.2018.06.047↗
  8. FDG-PET predicts treatment efficacy and surgical outcome of pre-operative chemoradiation therapy for resectable and borderline resectable pancreatic cancer. Last author DOI 10.1016/j.ejso.2017.03.015↗
  9. Preoperative Gemcitabine-based Chemoradiation Therapy for Borderline Resectable Pancreatic Cancer: Impact of Venous and Arterial Involvement Status on Surgical… Co-author DOI 10.1097/sla.0000000000001547↗
  10. Preoperative gemcitabine-based chemoradiation therapy for pancreatic ductal adenocarcinoma of the body and tail: impact of splenic vessels involvement on opera… Co-author DOI 10.1016/j.surg.2014.09.022↗
  11. [The progress of chemotherapy for advanced pancreatic cancer]. Last author DOI 10.11405/nisshoshi.112.2119↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hidenori Takahashi · 11 shared papers, 2015–2024 · strength 1.08
  2. Hirofumi Akita · 9 shared papers, 2015–2024 · strength 0.94
  3. Osamu Ishikawa · 7 shared papers, 2015–2023 · strength 0.63
  4. Shinichiro Hasegawa · 4 shared papers, 2020–2024 · strength 0.54
  5. Masahiko Yano · 6 shared papers, 2015–2020 · strength 0.38
  6. Hiroaki Ohigashi · 4 shared papers, 2015–2023 · strength 0.35
  7. Yosuke Mukai · 2 shared papers, 2023–2024 · strength 0.34
  8. Daisaku Yamada · 3 shared papers, 2020–2023 · strength 0.33
  9. Hidetoshi Eguchi · 2 shared papers, 2021–2023 · strength 0.31
  10. Hiroshi Wada · 1 shared paper, 2023 · strength 0.19
  11. Kunihito Gotoh · 2 shared papers, 2015–2021 · strength 0.15
  12. Manabu Mikamori · 1 shared paper, 2023 · strength 0.13
  13. Yuichiro Doki · 1 shared paper, 2021 · strength 0.11
  14. Yoshifumi Iwagami · 1 shared paper, 2021 · strength 0.11
  15. Yoshito Tomimaru · 1 shared paper, 2021 · strength 0.11
  16. Teruki Teshima · 1 shared paper, 2015 · strength 0.06
  17. Tatsuya Ioka · 1 shared paper, 2015 · strength 0.06
  18. Reiko Ashida · 1 shared paper, 2015 · strength 0.06
  19. Kazuhiro Katayama · 1 shared paper, 2015 · strength 0.06
  20. Yasuhiro Fujiwara · 1 shared paper, 2017 · strength 0.06
  21. Yoshiyuki Fujiwara · 1 shared paper, 2015 · strength 0.04
  22. Shigeru Marubashi · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.